African Swine Fever — Worldwide/Unknown
An African Swine Fever virus [ASFV] vaccine candidate has been adapted to grow in a cell line, which means that those involved in vaccine production will no longer have to rely on live pigs and their fresh cells for vaccine production.
That news was shared by the Agricultural Research Service (ARS), a section of the US Department of Agriculture (USDA). In a press release [see comment], senior ARS scientist Dr. Manuel Borca said, “This opens the door for large-scale vaccine production, which
…
